<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="preprint">
<?all-math-mml yes?>
<?use-mml?>
<?origin ukpmcpa?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">bioRxiv</journal-id>
<journal-title-group>
<journal-title>bioRxiv : the preprint server for biology</journal-title>
</journal-title-group>
<issn pub-type="ppub"/>
</journal-meta>
<article-meta>
<article-id pub-id-type="manuscript">EMS108895</article-id>
<article-id pub-id-type="doi">10.1101/2020.12.18.423467</article-id>
<article-id pub-id-type="archive">PPR256106</article-id>
<article-version article-version-type="publisher-id">1</article-version>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>assayM: a web application to monitor mutations in COVID-19 diagnostic assays</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Naeem</surname>
<given-names>Raeece</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pain</surname>
<given-names>Arnab</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Pathogen Genomics Laboratory, King Abdullah University of Science and Technology (KAUST), Thu-wal, 23955-6900, Kingdom of Saudi Arabia</aff>
<aff id="A2">
<label>2</label>Research Center for Zoonosis Control, Global Institution for Collaborative Research and Education (GI-CoRE); Hokkaido University, N20 W10 Kita-ku, Sapporo, 001-0020 Japan</aff>
<author-notes>
<corresp id="CR1">
<label>*</label>To whom correspondence should be addressed. <bold>Contact</bold>: <email>arnab.pain@kaust.edu.sa</email>
</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>24</day>
<month>12</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="preprint">
<day>18</day>
<month>12</month>
<year>2020</year>
</pub-date>
<permissions>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0 International license</ext-link>.</license-p>
</license>
</permissions>
<abstract>
<title>Summary</title>
<p id="P1">Reverse Transcriptase â€“ Polymerase Chain Reaction (RT-PCR) is the gold standard as diagnostic assays for the detection of COVID-19 and the specificity and sensitivity of these assays depend on the complementarity of the RT-PCR primers to the genome of the severe acute respiratory syndrome coro-navirus 2 (SARS-CoV-2). Since the virus mutates over time during replication cycles, there is an urgent need to continuously monitor the virus genome for appearances of mutations and mismatches in the PCR primers used in these assays. Here we present assayM, a web application to explore and monitor mutations introduced in the primer and probe sequences published by the World Health Organisation (WHO) or in any custom-designed assay primers for SARS-CoV-2 detection assays in globally available SARS-CoV-2 genome datasets.</p>
</abstract>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p id="P2">The gold standard for diagnosing the SARS-CoV2 virus is the RT-PCR. The PCR method involves a forward primer, reverse primer and probe to detect the presence of SARS-CoV2 virus infection. There are a number of PCR assays published in the literature (<xref ref-type="bibr" rid="R1">Khan and Cheung, 2020</xref>),(<xref ref-type="bibr" rid="R4">Wang, et al., 2020</xref>) and recommended by the World Health Organisation (WHO) (<ext-link ext-link-type="uri" xlink:href="https://www.who.int/docs/defaultsource/coronaviruse/whoinhouseassays.pdf">https://www.who.int/docs/defaultsource/coronaviruse/whoinhouseassays.pdf</ext-link>). The SARS-CoV2 virus continues to mutate and mutations appear in the regions where the assay primers bind to the RNA strand of the virus. As mutations accumulate in the target regions of the PCR primer and the probe binding region in the virus genome, the diagnostic efficacy of these assays gets reduced leading to false negative results in these tests(<xref ref-type="bibr" rid="R4">Wang, et al., 2020</xref>). It is imperative to monitor the mutations acquired in the target region to identify and redesign the primers to main a high level of sensitivity and specificity of the diagnostic assays. Samples of SARS-CoV2 virus strains are being sequenced across the world every day and made public through Genbank(<xref ref-type="bibr" rid="R2">Sayers, et al., 2020</xref>) and GISAID(<xref ref-type="bibr" rid="R3">Shu and McCauley, 2017</xref>). In order to track these mutations, we developed an exploratory web application assayM to visualize the impact of these mutations in the published RT-PCR primers and probes. This web application would be useful in designing PCR Primers with the least number of mutations. This application eases the time-consuming process of downloading newly available sequences and evaluating the diagnostic assays.</p>
<p id="P3">The web application is built using R language and scripts to compile the database of mutations is written in python and available to anyone to customize them according to their needs.</p>
</sec>
<sec id="S2">
<label>2</label>
<title>assayM web application</title>
<p id="P4">The core components required of the assayM web application are</p>
<p id="P5">Compiled list of published PCR primers and probe sequences. Catalog of curated Single Nucleotide Polymorphisms (SNPs) and Insertions and Deletions (Indels.)</p>
<p id="P6">Metadata such as date of collection and geographical origin of sequences. An integrated database and a visualization tool to search and filter regions of interest and track their changes over time.</p>
<p id="P7">PCR primers and probes were collated from (<xref ref-type="bibr" rid="R1">Khan and Cheung, 2020</xref>) where they evaluated 27 diagnostic probes and primers using a snapshot of 17,000 viral sequences available at that time. (<xref ref-type="bibr" rid="R4">Wang, et al., 2020</xref>) also evaluated published assays based on 31,421 sequences available in July, 2020. As of writing today there are in excess of 270,000 viral sequences available in the global repositories and continues to grow in thousands every two days. A catalog of curated SNPs and Indels are compiled from sequences available on Genbank and GISAID and good quality variants are made available for analysis every day on 2019 Novel Coronavirus Resource (<xref ref-type="bibr" rid="R6">Zhao, et al., 2020</xref>). The assayM python scripts pulls the curated multi-sample VCF file and its associated metadata from 2019 Novel Coronavirus resource on a weekly basis and builds an SQL database for querying and visualisation of the regions where the mutations occur.</p>
<sec id="S3">
<label>2.1</label>
<title>Exploring mutations in primer regions</title>
<p id="P8">The core functionality of assayM is to visualize the primer and probe regions and summarise the number of strains that have mutations in the target region. A genome browser with gene annotations is shown along with the primer and probe regions. (<xref ref-type="fig" rid="F1">Fig 1</xref>) The user has the ability to input and search their custom primer and probe sequences for a match against the SARS-CoV2 Wuhan-Hu-1 reference sequence (NCBI accession NC045512). The user can view any region of interest for mutations and obtain the mutation statistics. The bar graphs summarise the proportion of sequences that contain mutations against the total number of sequences deposited in the sequence repositories every month. By visualizing the mutation counts and proportion one can choose the primer regions when designing new primers and discard existing primers if there is an indica-tion of too many mutations that may result in reduction of specificity and sensitivity of the assays.</p>
</sec>
<sec id="S4">
<label>2.2</label>
<title>Compilation of published assays</title>
<p id="P9">A total of 34 diagnostic assays were compiled from literature review (<xref ref-type="bibr" rid="R1">Khan and Cheung, 2020</xref>; <xref ref-type="bibr" rid="R4">Wang, et al., 2020</xref>) and assays published on WHO website. Assays are listed in a table format where one can sort the primer sets according to most or least number of mutations. <xref ref-type="table" rid="T1">Table 1</xref> highlights 6 primer set where three of them contains the greatest number of mutations and the other three with the least number of mutations among the compiled set of 34 assays.</p>
</sec>
<sec id="S5">
<label>2.3</label>
<title>Detailed view on SNPs and Indels</title>
<p id="P10">A separate tab of the application lists all the mutations occurring across all regions of the SARS-CoV2 virus genome. For each mutation the genomic co-ordinates, strain name, sample collection date, country of origin, mutation type (SNP/Indel), reference and alternate alleles are displayed. The user can filter the table by genomic co-ordinates, country, collection date or mutation type.</p>
</sec>
<sec id="S6" sec-type="conclusions">
<label>2.4</label>
<title>Conclusion</title>
<p id="P11">Through assayM application we have included the most essential statistics on mutations related to diagnostic RT-PCR assays during the chaging landscape of the COVID-19 pandemic. As the source code is written in R shiny framework and the python scripts required to compile the mutation database is made available one can customize the R code to include more explorative charts and graphs on mutations in SARS-CoV2 virus.</p>
</sec>
</sec>
</body>
<back>
<ack id="S7">
<title>Acknowledgements</title>
<p>We thank KAUST Pathogen Genomics group members for their comments and support.</p>
<sec id="S8">
<title>Funding</title>
<p>This work has been supported by the KAUST Rapid Research Response Team (R3T) funding and the BAS/01-01-1020 fund to Arnab Pain</p>
</sec>
</ack>
<sec sec-type="data-availability" id="S9">
<title>Availability and implementation</title>
<p id="P12">assayM is available on <ext-link ext-link-type="uri" xlink:href="https://grafnet.kaust.edu.sa/assayM">https://grafnet.kaust.edu.sa/assayM</ext-link> as a web application and also as an open-source R shiny application, downloadable from <ext-link ext-link-type="uri" xlink:href="https://github.com/raeece/assayM">https://github.com/raeece/assayM</ext-link>
</p>
</sec>
<fn-group>
<fn id="FN1" fn-type="conflict">
<p id="P13">
<italic>Conflict of Interest:</italic> none declared.</p>
</fn>
</fn-group>
<ref-list>
<ref id="R1">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khan</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Cheung</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Presence of mismatches between diagnostic PCR assays and coronavirus SARS-CoV-2 genome</article-title>
<source>Roy Soc Open Sci</source>
<year>2020</year>
<volume>7</volume>
<issue>6</issue>
</element-citation>
</ref>
<ref id="R2">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sayers</surname>
<given-names>EW</given-names>
</name>
<etal/>
</person-group>
<article-title>GenBank</article-title>
<source>Nucleic Acids Res</source>
<year>2020</year>
<volume>48</volume>
<issue>D1</issue>
<fpage>D84</fpage>
<lpage>D86</lpage>
</element-citation>
</ref>
<ref id="R3">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shu</surname>
<given-names>YL</given-names>
</name>
<name>
<surname>McCauley</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>GISAID: Global initiative on sharing all influenza data - from vision to reality</article-title>
<source>Eurosurveillance</source>
<year>2017</year>
<volume>22</volume>
<issue>13</issue>
<fpage>2</fpage>
<lpage>4</lpage>
</element-citation>
</ref>
<ref id="R4">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>
<article-title>Mutations on COVID-19 diagnostic targets</article-title>
<source>Genomics</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R5">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>XL</given-names>
</name>
<etal/>
</person-group>
<article-title>Limits of Detection of 6 Approved RT-PCR Kits for the Novel SARS-Coronavirus-2 (SARS-CoV-2)</article-title>
<source>Clin Chem</source>
<year>2020</year>
<volume>66</volume>
<issue>7</issue>
<fpage>977</fpage>
<lpage>979</lpage>
</element-citation>
</ref>
<ref id="R6">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>WM</given-names>
</name>
<etal/>
</person-group>
<article-title>The 2019 novel coronavirus resource</article-title>
<source>Yi Chuan</source>
<year>2020</year>
<volume>42</volume>
<issue>2</issue>
<fpage>212</fpage>
<lpage>221</lpage>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="F1" position="float">
<label>Fig. 1</label>
<caption>
<title>Explore mutations in primer regions</title>
<p>A) This example show the number of strains with mutations in the CN-CDC-N primer set. B) Shows the proportion of strains that had mutations every month against the total number of strains deposited.</p>
</caption>
<graphic xlink:href="EMS108895-f001"/>
</fig>
<table-wrap id="T1" orientation="portrait" position="float">
<label>Table 1</label>
<caption>
<title>Table of assays with most number to least number of mutant strains.</title>
</caption>
<table frame="hsides" rules="rows">
<thead>
<tr style="border-top: hidden; border-bottom: hidden">
<th align="left" valign="middle">|S|</th>
<th align="left" valign="middle">Assay</th>
<th align="left" valign="middle">Mutant strains</th>
<th align="left" valign="middle">Assay Country</th>
<th align="left" valign="middle">Gene Target</th>
</tr>
</thead>
<tbody>
<tr>
<td style="border-bottom:hidden" align="left" valign="top">1</td>
<td style="border-bottom:hidden" align="left" valign="top">CN-CDC-N</td>
<td style="border-bottom:hidden" align="left" valign="top">67871</td>
<td style="border-bottom:hidden" align="left" valign="top">China</td>
<td style="border-bottom:hidden" align="left" valign="top">N</td>
</tr>
<tr>
<td style="border-bottom:hidden" align="left" valign="top">2</td>
<td style="border-bottom:hidden" align="left" valign="top">Young-S</td>
<td style="border-bottom:hidden" align="left" valign="top">7135</td>
<td style="border-bottom:hidden" align="left" valign="top">Singapore</td>
<td style="border-bottom:hidden" align="left" valign="top">S</td>
</tr>
<tr>
<td style="border-bottom:hidden" align="left" valign="top">3</td>
<td style="border-bottom:hidden" align="left" valign="top">SC2</td>
<td style="border-bottom:hidden" align="left" valign="top">6541</td>
<td style="border-bottom:hidden" align="left" valign="top">US</td>
<td style="border-bottom:hidden" align="left" valign="top">N</td>
</tr>
<tr>
<td style="border-bottom:hidden" align="left" valign="top"/>
<td style="border-bottom:hidden" align="left" valign="top"/>
<td style="border-bottom:hidden" align="left" valign="top"/>
<td style="border-bottom:hidden" align="left" valign="top"/>
<td style="border-bottom:hidden" align="left" valign="top"/>
</tr>
<tr>
<td style="border-bottom:hidden" align="left" valign="top">1</td>
<td style="border-bottom:hidden" align="left" valign="top">Won-ORFlab</td>
<td style="border-bottom:hidden" align="left" valign="top">608</td>
<td style="border-bottom:hidden" align="left" valign="top">South Korea</td>
<td style="border-bottom:hidden" align="left" valign="top">ORFlab</td>
</tr>
<tr>
<td style="border-bottom:hidden" align="left" valign="top">2</td>
<td style="border-bottom:hidden" align="left" valign="top">CN-CDC-ORFlab</td>
<td style="border-bottom:hidden" align="left" valign="top">903</td>
<td style="border-bottom:hidden" align="left" valign="top">China</td>
<td style="border-bottom:hidden" align="left" valign="top">ORFlab</td>
</tr>
<tr>
<td style="border-bottom:hidden" align="left" valign="top"/>
<td style="border-bottom:hidden" align="left" valign="top"/>
<td style="border-bottom:hidden" align="left" valign="top"/>
<td style="border-bottom:hidden" align="left" valign="top"/>
<td style="border-bottom:hidden" align="left" valign="top"/>
</tr>
<tr>
<td align="left" valign="top">3</td>
<td align="left" valign="top">Pasteur-ORFlab-1</td>
<td align="left" valign="top">909</td>
<td align="left" valign="top">France</td>
<td align="left" valign="top">ORFlab</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TFN1">
<p id="P14">Total number of strains deposited at the time of compiling this table is 261,988</p>
</fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>
